NovaGuide, the only autonomous transcranial Doppler ultrasound, is approved for use in Canada LOS ANGELES, Calif., March 15, 2022 (GLOBE NEWSWIRE) — NovaSignal Corp., a medical technology and data company specializing in the assessment and management of brain health, today announced that its NovaGuide™ Intelligent Ultrasound has been granted a Medical Device Licence […]

Clinical trial results show NovaGuide™ is three times more likely to detect RLS than transthoracic echocardiography Data presented in late-breaking science session at International Stroke Conference 2022 LOS ANGELES, Feb. 11, 2022 (GLOBE NEWSWIRE) — NovaSignal Corp., a medical technology and data company specializing in the assessment and management of brain […]